Version française
Biosquare
MERISTEM THERAPEUTICS at Biosquare 2007 Conference
       
   
 

«Medicines of the future will rely on biotechnology. It is essential to produce cost-effective pharmaceuticals without compromising quality and security in order to meet the demands of the public. It is the goal of MERISTEM Therapeutics to further advance therapeutic technology through the production of proteins in plants to provide lower cost pharmaceuticals.»

Jean-Paul Rohmer, CEO.

 
       
             
 
Why choose our technology for producing your proteins?
 
Partnerships tailored to meet your research and production needs
 
Merispase®: a recombinant lipase for cystic fibrosis treatment